Chronic Inflammation in Primary Myelofibrosis: In-Depth Insights Into Pathogenesis and Promising Anti-Inflammatory Therapeutic Strategies.

This study reviewed the role of chronic inflammation in primary myelofibrosis (PMF), a rare blood cancer that affects bone marrow. Researchers examined how inflammatory processes contribute to this disease by analyzing recent studies, including advanced single-cell genetic research. They found that PMF creates a complex inflammatory environment through three main mechanisms: overproduction of inflammatory chemicals called cytokines, increased oxidative stress (cellular damage), and dysfunction of the immune system. These inflammatory processes work together to worsen the disease, promote scarring in the bone marrow, and increase the risk of the condition transforming into leukemia. The researchers identified specific inflammatory pathways and cellular interactions that drive disease progression. For patients with PMF experiencing inflammation-related symptoms, this research is relevant because acupuncture has demonstrated anti-inflammatory effects in various conditions. Studies have shown acupuncture can help reduce inflammatory markers, modulate immune function, and decrease oxidative stress—the same mechanisms that are overactive in PMF. While this review doesn't specifically study acupuncture, it highlights inflammation as a key treatment target in PMF. Acupuncture may potentially serve as a complementary approach to help manage inflammatory symptoms, improve quality of life, and support conventional treatments, though more research is needed specifically in myelofibrosis patients. If considering acupuncture as part of a comprehensive care plan for PMF, patients should work with both their oncology team and a licensed acupuncturist experienced in treating cancer-related conditions.

This comprehensive review synthesizes recent research on inflammatory mechanisms in primary myelofibrosis (PMF), utilizing single-cell RNA sequencing data to elucidate pathogenic processes. The authors identify three interconnected inflammatory drivers: excessive cytokine production (including IL-1β, IL-6, TNF-α), heightened oxidative stress, and immune dysregulation involving both adaptive and innate immunity. Key findings detail how malignant hematopoietic cells interact with bone marrow stromal cells through specific cytokine pathways, promoting clonal expansion, fibrosis, and leukemic transformation. The review emphasizes JAK2, CALR, and MPL mutations as underlying genetic factors contributing to inflammatory dysregulation. Clinical relevance for acupuncture practitioners includes understanding PMF as an inflammation-driven malignancy where anti-inflammatory interventions may provide therapeutic benefit. Acupuncture's documented effects on cytokine modulation, oxidative stress reduction, and immune regulation suggest potential complementary value, particularly for symptom management and quality of life. Practitioners should coordinate closely with oncology teams and monitor for contraindications including thrombocytopenia-related bleeding risks and infection susceptibility in immunocompromised patients.